Review article · 2025 · Open access
Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review
Frontiers in Pharmacology, 16, 1644907 · Published 24 September 2025 · DOI 10.3389/fphar.2025.1644907
In brief
“Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review” is a 2025 review article by Rahul Mittal and 6 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 12 citations as of 15 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.
- Citations
- 12
- Most cited in
- 2026 (12)
- Field-weighted impact
- 1.75
- References
- 113
- Authors
- 7
Abstract
Introduction: The growing limitations of animal models in drug testing and biomedical research, including ethical concerns, high costs, and poor translational relevance to human biology, have driven increasing interest in computational simulation models. These models encompass in silico approaches, pharmacokinetic/pharmacodynamic frameworks, molecular simulations, and organ-on-chip technologies, offering greater precision in replicating human physiological and pathological processes. Methods: A systematic review was conducted to examine the role of computational simulation models as alternatives to traditional animal-based research. Relevant literature on their applications, predictive accuracy, translational value, and alignment with ethical research practices was analyzed. Results: Computational models were found to bridge critical gaps in predictive accuracy and translational relevance, supporting drug development pipelines, reducing late-stage failures, and enhancing opportunities for personalized medicine. Additionally, their capacity to reduce reliance on animal models aligns with global ethical initiatives promoting humane and sustainable research practices. Discussion: Simulation-based approaches represent a transformative opportunity for biomedical research. While their potential to reshape drug development and improve health outcomes is evident, challenges such as standardization, scalability, and regulatory integration remain. Addressing these barriers will be essential to fully realize the potential of computational simulation models in replacing or reducing animal testing and advancing human-centered biomedical innovation. Systematic Review Registration: identifier, INPLASY2024110028.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Mittal, R., Ho, A., Adivikolanu, H., Sawhney, M., Lemos, J. R. N., Mittal, M., & Hirani, K. (2025). Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review. Frontiers in Pharmacology, 16, 1644907. https://doi.org/10.3389/fphar.2025.1644907
MLA 9
Mittal, Rahul, et al. “Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review.” Frontiers in Pharmacology, vol. 16, 2025, p. 1644907. https://doi.org/10.3389/fphar.2025.1644907.
Chicago
Mittal, Rahul, Alan Ho, Harini Adivikolanu, Muskaan Sawhney, Joana R. N. Lemos, Mannat Mittal, and Khemraj Hirani. 2025. “Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review.” Frontiers in Pharmacology 16: 1644907. https://doi.org/10.3389/fphar.2025.1644907.
Harvard
Mittal, R. et al. (2025) ‘Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review’, Frontiers in Pharmacology, 16, p. 1644907. doi:10.3389/fphar.2025.1644907.
IEEE
R. Mittal et al., “Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review,” Frontiers in Pharmacology, vol. 16, p. 1644907, 2025, doi: 10.3389/fphar.2025.1644907.
BibTeX
@article{mittal2025exploring,
title = {{Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review}},
author = {Mittal, Rahul and Ho, Alan and Adivikolanu, Harini and Sawhney, Muskaan and Lemos, Joana R. N. and Mittal, Mannat and Hirani, Khemraj},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
pages = {1644907},
doi = {10.3389/fphar.2025.1644907},
url = {https://doi.org/10.3389/fphar.2025.1644907}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- computer simulation
- alternatives to animal testing
- organ-on-a-chip
- pharmacokinetic-pharmacodynamic modeling
- molecular simulation
- translational research
- prediction accuracy
- drug development
Work with this paper
Most-cited papers in Veterinary
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysTim R. Mosmann · Journal of Immunological Methods · 1983 · 57,115 citations
- Guide for the Care and Use of Laboratory Animals: Eighth EditionNational Research Council · National Academies Press eBooks · 2011 · 16,572 citations
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningPhilip Skehan, Ritsa Storeng, Dominic A. Scudiero and 7 more · JNCI Journal of the National Cancer Institute · 1990 · 9,860 citations
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchCarol Kilkenny, William J. Browne, Innes C. Cuthill and 2 more · PLoS Biology · 2010 · 7,617 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia and 25 more · PLoS Biology · 2020 · 6,761 citations
Questions about this paper
How do I cite this paper in APA style?
Mittal, R., Ho, A., Adivikolanu, H., Sawhney, M., Lemos, J. R. N., Mittal, M., & Hirani, K. (2025). Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review. Frontiers in Pharmacology, 16, 1644907. https://doi.org/10.3389/fphar.2025.1644907
How many times has this paper been cited?
12 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Frontiers in Pharmacology.
Who wrote this paper?
Rahul Mittal, Alan Ho, Harini Adivikolanu, Muskaan Sawhney, Joana R. N. Lemos, Mannat Mittal, Khemraj Hirani.
What is the DOI of this paper?
10.3389/fphar.2025.1644907. The permanent link is https://doi.org/10.3389/fphar.2025.1644907.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.